Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-17

Clinical Trial Update: Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating capecitabine and albumin-stabilized nanoparticle formulation with paclitaxel in women undergoing surgery for stage II/III breast …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capecitabine and paclitaxel (albumin-stabilized nanoparticle formulation)

Snippet

Sponsor: Medstar Health Research Institute | Conditions: Breast Cancer | Phase 2, Phase 3 | Status: WITHDRAWN